Zacks.com on MSN
Pfizer (PFE) Stock Sinks As Market Gains: Here's Why
In the latest trading session, Pfizer (PFE) closed at $23.72, marking a -2.47% move from the previous day. The stock trailed ...
Pfizer's IBRANCE has received new FDA approval as the first CDK4/6 inhibitor maintenance therapy for HR+, HER2+ metastatic ...
Discover 5 top Big Pharma stocks amid rising cancer, type 2 diabetes and IMIDs—dividend yields, earnings beats and why they ...
Futures are trading higher as we get ready to start the first full week of trading for the third quarter, as traders and ...
HSBC downgraded Pfizer Inc. PFE on Monday, citing that the company’s near-term re-rating prospects have weakened despite its ...
Zacks.com on MSN
Can Alnylam's Drug Pipeline Fuel Its Long-Term Revenue Growth?
Alnylam Pharmaceuticals ALNY currently markets four approved drugs — Onpattro, Givlaari, Oxlumo and Amvuttra — that together ...
Morgan Stanley downgraded Affirm from “Overweight” to “Equal Weight” on June 25, simultaneously removing the stock from its ...
One stands above the others.
Stockhead on MSN
Resources Top 5: Hammer Metals fields Austral offer; Western Ridge samples high-grade silver and gold
Hammer Metals considering takeover offer from Austral over Larvotto bid; Western Ridge samples high-grade silver and gold at ...
WHO’s adaptive Ebola trial in Congo tests MBP134 and remdesivir vs supportive care for Bundibugyo strain, tracking 28-day mortality—read the update now.
The iShares Select Dividend ETF (NASDAQ:DVY) has quietly rewarded income investors with a 21.05% gain over the past year, all ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results